Kyoto University
Department of Early Clinical Development Graduate School of MedicineKyoto University HospitalDepartment of Early Clinical DevelopmentKyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT)
December 2020 to March 2022 We conducted the following clinical trial. “A bioequivalence Study of an Anti-Cancer Drug in Healthy Volunteers”
Next Generation Medical and iPS Cell Therapy Research Center(Ki-CONNECT) Early Medical Development Department Assistant professor, Masaru Fukahori has been appointed.
June 2020 to March 2021 We conducted the following clinical trial “A Bioequivalence Study of a central Nervous System Acting Drug in Healthy Volunteers”
April 2019 to March 2021 Takako Nakajima(Principal Investigator)implemented the project(Japan Agency for Medical Research and Development) “Evaluation of DEX(steroid) sparing for high emetogenic chemotherapy”
新しい投稿 »